{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T05:10:06Z","timestamp":1749273006081,"version":"3.41.0"},"reference-count":36,"publisher":"Japanese Society of Toxicology","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2025]]},"DOI":"10.2131\/jts.50.273","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T22:11:48Z","timestamp":1748729508000},"page":"273-281","source":"Crossref","is-referenced-by-count":0,"title":["Dabrafenib stimulates autophagy in thyroid carcinoma cells via HMGB-1"],"prefix":"10.2131","volume":"50","author":[{"given":"Xu","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Surgery II, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dianchao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The First Hospital of Qiqihaer, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Out-patient department, Harbin Red Cross Central Hospital, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengjuan","family":"Han","sequence":"additional","affiliation":[{"name":"Departments of Gynecology III, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"Boucai, L., Zafereo, M. and Cabanillas, M.E. (2024): Thyroid Cancer: A Review. JAMA, <b>331<\/b>, 425-435.","DOI":"10.1001\/jama.2023.26348"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Bouffet, E., Hansford, J.R., Garr\u00e8, M.L., Hara, J., Plant-Fox, A., Aerts, I., Locatelli, F., van der Lugt, J., Papusha, L., Sahm, F., Tabori, U., Cohen, K.J., Packer, R.J., Witt, O., Sandalic, L., Bento Pereira da Silva, A., Russo, M. and Hargrave, D.R. (2023): Dabrafenib plus Trametinib in Pediatric Glioma with <i>BRAF<\/i> V600 Mutations. N. Engl. J. Med., <b>389<\/b>, 1108-1120.","DOI":"10.1056\/NEJMoa2303815"},{"key":"3","first-page":"1184","author":"N.L. Busaidy","year":"2022","unstructured":"Busaidy, N.L., Konda, B., Wei, L., Wirth, L.J., Devine, C., Daniels, G.A., DeSouza, J.A., Poi, M., Seligson, N.D., Cabanillas, M.E., Sipos, J.A., Ringel, M.D., Eisfeld, A.K., Timmers, C. and Shah, M.H. (2022): Dabrafenib Versus Dabrafenib + Trametinib in <i>BRAF<\/i>-Mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer: Results of a Randomized, Phase 2, Open-Label Multicenter Trial. Thyroid, <b>32<\/b>, 1184-1192.","journal-title":"Thyroid","ISSN":"https:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Cao, W., Li, J., Yang, K. and Cao, D. (2021): An overview of autophagy: Mechanism, regulation and research progress. Bull. Cancer, <b>108<\/b>, 304-322.","DOI":"10.1016\/j.bulcan.2020.11.004"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Casciaro, M., Di Salvo, E. and Gangemi, S. (2021): HMGB-1 in Psoriasis. Biomolecules, <b>12<\/b>, 1-15.","DOI":"10.3390\/biom12010060"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Chen, D.W., Lang, B.H., McLeod, D.S., Newbold, K. and Haymart, M.R. (2023): Thyroid cancer. Lancet, <b>401<\/b>, 1531-1544.","DOI":"10.1016\/S0140-6736(23)00020-X"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Cheng, C., Zhu, R., Liu, M., Yang, H., Guo, F., Du, Q., Wang, X., Li, M., Song, G., Qin, R. and Liu, S. (2023): Kunxian capsule alleviates renal damage by inhibiting the JAK1\/STAT1 pathway in lupus nephritis. J. Ethnopharmacol., <b>310<\/b>, 116349.","DOI":"10.1016\/j.jep.2023.116349"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Debnath, J., Gammoh, N. and Ryan, K.M. (2023): Autophagy and autophagy-related pathways in cancer. Nat. Rev. Mol. Cell Biol., <b>24<\/b>, 560-575.","DOI":"10.1038\/s41580-023-00585-z"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Dong, G., You, M., Fan, H., Ding, L., Sun, L. and Hou, Y. (2015): STS-1 promotes IFN-\u03b1 induced autophagy by activating the JAK1-STAT1 signaling pathway in B cells. Eur. J. Immunol., <b>45<\/b>, 2377-2388.","DOI":"10.1002\/eji.201445349"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Fu, L., Zhao, L., Liao, C., Wang, P., Gu, Y., Li, S., Shi, L., Wang, Q., Xie, J., Zhang, L., Liu, X. and Zhang, B. (2023): Knockdown of KAT5\/KIF11 induces autophagy and promotes apoptosis in anaplastic thyroid cancer cells. Exp. Ther. Med., <b>25<\/b>, 247.","DOI":"10.3892\/etm.2023.11946"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Fung, S.Y., Siu, K.L., Lin, H., Chan, C.P., Yeung, M.L. and Jin, D.Y. (2022): SARS-CoV-2 NSP13 helicase suppresses interferon signaling by perturbing JAK1 phosphorylation of STAT1. Cell Biosci., <b>12<\/b>, 36.","DOI":"10.1186\/s13578-022-00770-1"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Holm, T.M., Yeo, S., Turner, K.M. and Guan, J.L. (2022): Targeting Autophagy in Thyroid Cancer: EMT, Apoptosis, and Cancer Stem Cells. Front. Cell Dev. Biol., <b>10<\/b>, 821855.","DOI":"10.3389\/fcell.2022.821855"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Huang, J., Chen, X. and Lv, Y. (2021): HMGB1 Mediated Inflammation and Autophagy Contribute to Endometriosis. Front. Endocrinol. (Lausanne), <b>12<\/b>, 616696.","DOI":"10.3389\/fendo.2021.616696"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Kama\u015fak, T., Dilber, B., Yaman, S.O., Durgut, B.D., Kurt, T., \u00c7oban, E., Arslan, E.A., \u015eahin, S., Karahan, S.C. and Cansu, A. (2020): HMGB-1, TLR4, IL-1R1, TNF-\u03b1, and IL-1\u03b2: novel epilepsy markers? Epileptic Disord., <b>22<\/b>, 183-193.","DOI":"10.1684\/epd.2020.1155"},{"key":"15","doi-asserted-by":"crossref","unstructured":"King, A.J., Arnone, M.R., Bleam, M.R., Moss, K.G., Yang, J., Fedorowicz, K.E., Smitheman, K.N., Erhardt, J.A., Hughes-Earle, A., Kane-Carson, L.S., Sinnamon, R.H., Qi, H., Rheault, T.R., Uehling, D.E. and Laquerre, S.G. (2013): Dabrafenib; preclinical characterization, increased efficacy when combined with trametinib, while BRAF\/MEK tool combination reduced skin lesions. PLoS One, <b>8<\/b>, e67583.","DOI":"10.1371\/journal.pone.0067583"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Lamark, T., Svenning, S. and Johansen, T. (2017): Regulation of selective autophagy: the p62\/SQSTM1 paradigm. Essays Biochem., <b>61<\/b>, 609-624.","DOI":"10.1042\/EBC20170035"},{"key":"17","first-page":"1","author":"T. Li","year":"2022","unstructured":"Li, T., Li, L., Peng, R., Hao, H., Zhang, H., Gao, Y., Wang, C., Li, F., Liu, X., Chen, F., Zhang, S. and Zhang, J. (2022): Abrocitinib Attenuates Microglia-Mediated Neuroinflammation after Traumatic Brain Injury via Inhibiting the JAK1\/STAT1\/NF-\u03baB Pathway. Cells, <b>11<\/b>, 1-17.","journal-title":"Cells","ISSN":"https:\/\/id.crossref.org\/issn\/2073-4409","issn-type":"print"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Lian, C., Huang, Y., Hu, P., Cao, Y., Zhang, Z., Feng, F. and Zhang, J. (2023): Nitidine Chloride Triggers Autophagy and Apoptosis of Ovarian Cancer Cells through Akt\/mTOR Signaling Pathway. Curr. Pharm. Des., <b>29<\/b>, 1524-1534.","DOI":"10.2174\/1381612829666230614154847"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Liu, Z., Jiang, Y., Fang, Q., Yuan, H., Cai, N., Suo, C., Ye, W., Chen, X. and Zhang, T. (2019): Future of cancer incidence in Shanghai, China: predicting the burden upon the ageing population. Cancer Epidemiol., <b>60<\/b>, 8-15.","DOI":"10.1016\/j.canep.2019.03.004"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Long, G.V., Flaherty, K.T., Stroyakovskiy, D., Gogas, H., Levchenko, E., de Braud, F., Larkin, J., Garbe, C., Jouary, T., Hauschild, A., Chiarion-Sileni, V., Lebbe, C., Mandal\u00e0, M., Millward, M., Arance, A., Bondarenko, I., Haanen, J.B., Hansson, J., Utikal, J., Ferraresi, V., Mohr, P., Probachai, V., Schadendorf, D., Nathan, P., Robert, C., Ribas, A., Davies, M.A., Lane, S.R., Legos, J.J., Mookerjee, B. and Grob, J.J. (2017): Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E\/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study. Ann. Oncol., <b>28<\/b>, 1631-1639.","DOI":"10.1093\/annonc\/mdx176"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Lorimer, C., Cheng, L., Chandler, R., Garcez, K., Gill, V., Graham, K., Grant, W., Sardo Infirri, S., Wadsley, J., Wall, L., Webber, N., Wong, K.H. and Newbold, K. (2023): Dabrafenib and Trametinib Therapy for Advanced Anaplastic Thyroid Cancer - Real-World Outcomes From UK Centres. Clin. Oncol. (R. Coll. Radiol.), <b>35<\/b>, e60-e66.","DOI":"10.1016\/j.clon.2022.10.017"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Lu, Y., Chen, Y., Li, Y., Xu, S., Lian, D., Liang, J., Jiang, D., Chen, S. and Hou, S. (2023): Monotropein inhibits colitis associated cancer through VDR\/JAK1\/STAT1 regulation of macrophage polarization. Int. Immunopharmacol., <b>124<\/b> (Pt A), 110838.","DOI":"10.1016\/j.intimp.2023.110838"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Ma, Y., Tang, T., Sheng, L., Wang, Z., Tao, H., Zhang, Q., Zhang, Y. and Qi, Z. (2018): Aloin suppresses lipopolysaccharide-induced inflammation by inhibiting JAK1-STAT1\/3 activation and ROS production in RAW264.7 cells. Int. J. Mol. Med., <b>42<\/b>, 1925-1934.","DOI":"10.3892\/ijmm.2018.3796"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Menzies, A.M., Long, G.V. and Murali, R. (2012): Dabrafenib and its potential for the treatment of metastatic melanoma. Drug Des. Devel. Ther., <b>6<\/b>, 391-405.","DOI":"10.2147\/DDDT.S38998"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Nabhan, F., Dedhia, P.H. and Ringel, M.D. (2021): Thyroid cancer, recent advances in diagnosis and therapy. Int. J. Cancer, <b>149<\/b>, 984-992.","DOI":"10.1002\/ijc.33690"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Ott, N., Faletti, L., Heeg, M., Andreani, V. and Grimbacher, B. (2023): JAKs and STATs from a Clinical Perspective: Loss-of-Function Mutations, Gain-of-Function Mutations, and Their Multidimensional Consequences. J. Clin. Immunol., <b>43<\/b>, 1326-1359.","DOI":"10.1007\/s10875-023-01483-x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Prerna, K. and Dubey, V.K. (2022): Beclin1-mediated interplay between autophagy and apoptosis: new understanding. Int. J. Biol. Macromol., <b>204<\/b>, 258-273.","DOI":"10.1016\/j.ijbiomac.2022.02.005"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Qu, N., Qu, J., Huang, N., Zhang, K., Ye, T., Shi, J., Chen, B., Kan, C., Zhang, J., Han, F., Hou, N., Sun, X. and Pan, R. (2022): Calycosin induces autophagy and apoptosis <i>via<\/i> Sestrin2\/AMPK\/mTOR in human papillary thyroid cancer cells. Front. Pharmacol., <b>13<\/b>, 1056687.","DOI":"10.3389\/fphar.2022.1056687"},{"key":"29","doi-asserted-by":"publisher","unstructured":"Shobab, L., Burman, K.D. and Wartofsky, L. (2022): Sex Differences in Differentiated Thyroid Cancer. Thyroid, <b>32<\/b>, 224-235.","DOI":"10.1089\/thy.2021.0361"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Singh, A., Gupta, N., Khandakar, H., Kaushal, S., Seth, A., Pandey, R.M. and Sharma, A. (2022): Autophagy-associated HMGB-1 as a novel potential circulating non-invasive diagnostic marker for detection of Urothelial Carcinoma of Bladder. Mol. Cell. Biochem., <b>477<\/b>, 493-505.","DOI":"10.1007\/s11010-021-04299-8"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Subbiah, V., Kreitman, R.J., Wainberg, Z.A., Cho, J.Y., Schellens, J.H., Soria, J.C., Wen, P.Y., Zielinski, C.C., Cabanillas, M.E., Boran, A., Ilankumaran, P., Burgess, P., Romero Salas, T. and Keam, B. (2022): Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study. Ann. Oncol., <b>33<\/b>, 406-415.","DOI":"10.1016\/j.annonc.2021.12.014"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Tanida, I., Ueno, T. and Kominami, E. (2004): LC3 conjugation system in mammalian autophagy. Int. J. Biochem. Cell Biol., <b>36<\/b>, 2503-2518.","DOI":"10.1016\/j.biocel.2004.05.009"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Tanida, I., Ueno, T. and Kominami, E. (2008): LC3 and Autophagy. Methods Mol. Biol., <b>445<\/b>, 77-88.","DOI":"10.1007\/978-1-59745-157-4_4"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Xu, H.D. and Qin, Z.H. (2019): Beclin 1, Bcl-2 and Autophagy. Adv. Exp. Med. Biol., <b>1206<\/b>, 109-126.","DOI":"10.1007\/978-981-15-0602-4_5"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Xu, Z., Xi, F., Deng, X., Ni, Y., Pu, C., Wang, D., Lou, W., Zeng, X., Su, N., Chen, C., Zeng, Z., Deng, L. and Jiang, M. (2023): Osteopontin Promotes Macrophage M1 Polarization by Activation of the JAK1\/STAT1\/HMGB1 Signaling Pathway in Nonalcoholic Fatty Liver Disease. J. Clin. Transl. Hepatol., <b>11<\/b>, 273-283.","DOI":"10.14218\/JCTH.2021.00474"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Zaman, A., Wu, W. and Bivona, T.G. (2019): Targeting Oncogenic BRAF: Past, Present, and Future. Cancers (Basel), <b>11<\/b>, 1234.","DOI":"10.3390\/cancers11081197"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/50\/6\/50_273\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T04:45:29Z","timestamp":1749271529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/50\/6\/50_273\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.50.273","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"type":"print","value":"0388-1350"},{"type":"electronic","value":"1880-3989"}],"subject":[],"published":{"date-parts":[[2025]]}}}